Tylenol faces another recall

By
A A A

The manufacturer of Tylenol products has found itself under scrutiny for the second time this month.

CNN reports Johnson & Johnson ( JNJ ) has called back more Tylenol-based medications amidst complaints from consumers about smells that are musty and moldy. Earlier this month, the U.S. government announced plans to take over three Tylenol plants that were operated by McNeil, which also manufactures Motrin and Benadryl.

The most recent recall pertains to a surveillance effort. One lot, which is 34,000 bottles, of Tylenol 8 Hour extended release caplets is the focus of this recall. The Tylenol product in point was manufactured in the Fort Washington, Pennsylvania plant before that site was closed in April 2010.

Last year, McNeil called back in excess of 50 million bottles of Tylenol, Motrin and Benadryl because of the same complaints about moldy and musty odors. Trace amounts of a chemical called 2,4,6-tribromoanisole, which is used on wooden shipping pallets, were to blame, according to company officials.

McNeil again pointed to the same cause as being responsible for the same complaints.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Personal Finance , Business

Referenced Stocks: JNJ

NASDAQ.com News

NASDAQ.com News

More from NASDAQ.com News:

Related Videos

Stocks

Referenced

77%

Most Active by Volume

85,117,424
  • $6.78 ▲ 11.88%
77,261,676
  • $17.53 ▲ 1.56%
61,066,548
  • $6.90 ▲ 2.99%
56,847,440
  • $112.65 ▲ 2.96%
52,788,366
  • $7.78 ▲ 1.83%
50,761,400
  • $25.14 ▲ 2.91%
47,781,237
  • $45.35 ▲ 10.18%
45,664,909
  • $7.17 ▲ 2.14%
As of 12/18/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com